Clearmind Medicine Inc (CMND)
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer
Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update